San Francisco, USA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Pan-Genomic and Multi-Gene Panel Testing Market reached a valuation of US$ 8,907.34 million in 2024 and is projected to grow steadily over the ...
We conducted a retrospective database analysis using medical and pharmacy claims data. Medicare Advantage Prescription Drug Plan members diagnosed with select malignant solid tumors were identified.
Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative We conducted a retrospective database analysis using medical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results